Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00549_DB00622> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00549_DB00622 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00549_DB00622 label "DDI between Zafirlukast and Nicardipine - Nicardipine, a strong CYP2C9 inhibitor, may decrease the metabolism and clearance of zafirlukast. Consider alternate therapy or monitor for changes in zafirlukast therapeutic and adverse effects if nicardipine is initiated, discontinued or dose changed. [drugbank_resource:DB00549_DB00622]" assertion.
- drugbank_resource:DB00549_DB00622 identifier "drugbank_resource:DB00549_DB00622" assertion.
- drugbank_resource:DB00549_DB00622 title "DDI between Zafirlukast and Nicardipine - Nicardipine, a strong CYP2C9 inhibitor, may decrease the metabolism and clearance of zafirlukast. Consider alternate therapy or monitor for changes in zafirlukast therapeutic and adverse effects if nicardipine is initiated, discontinued or dose changed." assertion.